YCharOS antibody characterization platform addresses the 鈥渞eproducibility crisis鈥� in research...
$400,000 will fuel public-private collaboration to discover new disease biomarkers...
Projects include important research on Parkinson鈥檚, glioblastoma and dementia 聽
NeuRo Genomics Initiative will help better understand rare and aging-related neurological disorders affecting Canadians...
Academic and industry scientists collaborate on a new method to characterize research antibodies
Since becoming only the second Alzheimer鈥檚-modifying drug to gain American FDA approval in 2023, sales of lecanemab, known by its brand name Leqembi, have risen steadily, reaching $87-million USD...
$1.14 million from CIHR will resolve treatment roadblocks for rare brain disorders...
Free, online training program strengthens training and brings specialized care to communities across Quebec...
Mapping immune cell diversity reveals dexamethasone鈥檚 impact on brain cancer immunotherapy...
RSS